Palisade Bio (PALI) Accounts Payables (2010 - 2026)
Palisade Bio (PALI) posted quarterly Accounts Payables of $2.7 million for Q1 2026, up 261.88% year-over-year from $745000.0 in Q1 2025, and up 251.5% quarter-over-quarter from $767000.0 in Q4 2025.
Palisade Bio (PALI) Accounts Payables (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Accounts Payables for 17 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 261.88% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (up 261.88% YoY), while the FY2025 annual figure was $767000.0, down 30.59% from the prior year.
- Accounts Payables climbed to $2.7 million in Q1 2026 per PALI's latest filing, from $767000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.7 million in Q1 2026 and bottomed at $366000.0 in Q3 2024.
- Historically, Accounts Payables has averaged $1.1 million across 5 years, with a median of $950000.0 in 2023.
- Annual changes were most pronounced in 2024 — Accounts Payables plunged 61.47% — and 2025, when it soared 289.62%.
- Palisade Bio's Accounts Payables stood at $1.8 million in 2022, then sank by 60.32% to $698000.0 in 2023, then jumped by 58.31% to $1.1 million in 2024, then tumbled by 30.59% to $767000.0 in 2025, then soared by 251.5% to $2.7 million in 2026.
- Business Quant data shows PALI's Accounts Payables at $2.7 million in Q1 2026, $767000.0 in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 745,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 366,000.00 |
| Jun 30, 2024 | 514,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Sep 30, 2023 | 950,000.00 |
| Jun 30, 2023 | 922,000.00 |
| Mar 31, 2023 | 706,000.00 |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.73 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.38 Mn |